Back to results
US 2025/0205154 A1Published application
Liquid formulation pharmaceutical composition comprising plasmid dna
AssigneeHelixmith Co., Ltd
InventorsKyungdong BAE, Yunyeol JO, Jihwan PARK
Life of this patent
Estimating the term…
Abstract
The present invention relates to a liquid formulation pharmaceutical composition comprising plasmid DNA. The liquid formulation comprising plasmid DNA according to the present invention shows excellent efficacy in terms of storage stability of plasmid DNA, which is a pharmaceutically active ingredient, and accordingly, can be useful as a pharmaceutical composition with excellent product stability and safety.
Claims20
A liquid formulation of plasmid DNA, comprising 30-50 mM potassium phosphate, 0.5-1.5% NaCl, and plasmid DNA, with a pH of 7.5-8.5.
Dependencies are inferred from the claim text.